Hemoglobinopathies in the Neonate.

Neoreviews

Division of Hematology/Oncology, Department of Pediatrics, Children's Hospital at Montefiore, Albert Einstein College of Medicine, New York, NY.

Published: November 2024

Hemoglobinopathies in neonates constitute a group of disorders influenced by genetic mutations in the human globin genes. They are often broadly categorized into quantitative defects or qualitative defects, though they are not mutually exclusive. In quantitative defects, the mutation causes insufficient production of a normal globin chain, which can range from no production to mild deficiency. These are typically referred to as thalassemias. In qualitative defects, the structure of the hemoglobin is altered. The most common structural hemoglobinopathy is sickle cell disease. During fetal development, distinct globin chains are synthesized, which undergo a progressive switch to adult globin chains perinatally. This affects the timing of the clinical presentation of these disorders and thus, our ability to diagnose them. In this review, we focus on the epidemiology, genetic causes, clinical presentation, and general overview and management of common hemoglobin disorders that may be encountered in the neonatal period.

Download full-text PDF

Source
http://dx.doi.org/10.1542/neo.25-11-e720DOI Listing

Publication Analysis

Top Keywords

quantitative defects
8
qualitative defects
8
globin chains
8
clinical presentation
8
hemoglobinopathies neonate
4
neonate hemoglobinopathies
4
hemoglobinopathies neonates
4
neonates constitute
4
constitute group
4
group disorders
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!